SUMMARY Twelve patients treated with isotretinoin, a synthetic vitamin A analogue, were assessed before, during, and after therapy. Significant falls occurred in the amplitude of the a waves of the scotopic electroretinogram.
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Vitamin A has been used topically and systemically in the treatment of skin disease for some 40 years. ' Analogues of vitamin A (synthetic retinoids) have been developed which have a better therapeutic ratio than the vitamin, and these analogues are now widely used in dermatological practice. Symptomatic dry eye and blepharitis are well described side effects of these drugs,2 4 but recent reports56 suggest that these synthetic retinoids may interfere with retinal function.
This pilot study was set up to investigate prospectively the effect of synthetic analogues of vitamin A on visual function.
Patients and methods
Seventeen patients about to be treated with a synthetic retinoid preparation (isotretinoin) for a dermatological condition, were referred for a pretreatment assessment. This assessment included a full ophthalmic history and examination, visual field testing, electroretinography (ERG), electrooculography (EOG), and dark adaptation (DA) studies. The patients were assessed again at one month and three months after starting treatment. The treatment was a four-month course, and it was intended that any subject showing abnormalities would be reassessed one month after stopping treatment; however, this was not always realised in practice.
One patient treated with another retinoid (etretinate) was included in the study and the results are presented separately.
Results
Of the 17 The results of the white scotopic ERG a and b waves are shown in Tables 1 and 2 respectively. The attendance is obviously far from satisfactory. Certain subjects show a drop in ERG amplitude in both a and b waves (for example, patient 9) from the pretreatment values to values found during treatment.
Only seven patients had attended for pretreatment assessment and at three months of treatment. These seven paired results (bold type in Tables 1 and 2) were analysed by the two-tailed paired t test. The analysis showed that the a wave results for both the right and left eyes showed a significant fall (t= -2-60 and t= -2-80 respectively, with 6 degrees of freedom, p<0-05). The b wave changes, however, were not significant (t= -1-47 and t= -1.67). 
Rx =treament.
The one patient (13) using etretinate showed a large and sustained drop in both a and b waves which has not markedly improved since stopping treatment (Table 3) . This fits well with the known pharmacodynamics of this drug. Retinol is involved in the functioning of the photoreceptors and so one might expect the primary components of the ERG (early receptor potential and a wave) to be affected more than the later components (b wave). This fits with our data where a wave but not b wave changes occur. Some of our subjects show suggestive changes in the b wave, and with larger numbers there might prove to be significant falls in this component of the ERG. The early receptor potential was not looked at in this study, but changes have been reported with etretinate suggesting disturbance of the primary photochemical process. 9 While isotretinoin has a fairly short half life, etretinate is stored in fat and has a prolonged effect. "I The one patient taking etretinate has shown a correspondingly prolonged reduction in his a and b wave amplitudes.
STATISTICS
In view of the large number of patients taking these drugs it is impractical to screen them all for visual toxicity. However, until the effects of these synthetic analogues of vitamin A are better understood, we suggest that any patients complaining of difficulties in night vision or with colour vision abnormalities9 should be reviewed. Certainly patients in those occupations where reduced night vision or colour sensitivity would be a problem, such as the armed forces or merchant seamen, may well require more detailed observation. 
